The 8th Japan-China Joint Meeting of Basic and Clinical Pharmacology
On behalf of the Japanese Pharmacological Society and the Organizing Committee of the 94th Annual Meeting of the Japanese Pharmacological Society, we cordially invite you to attend the 8th Japan-China Joint Meeting of Basic and Clinical Pharmacology. This joint meeting will be held as the Japan-China Joint Session of the 94th Annual Meeting of the Japanese Pharmacological Society held in Sapporo on March 10, 2021.
The last Japan-China Joint Meeting of Basic and Clinical Pharmacology was organized by the Chinese Pharmacological Society, and it was held in Kunming, Yunnan Province, China, at August 4-5, 2019. The Japan-China Joint Meeting has picked up the most advanced topics on pharmacology and contributes great progress of pharmacological sciences in both countries. It should be noted that young pharmacologists and students in both countries could get to know each other through the Joint Meeting, and had grown up to leading the pharmacological sciences in both countries.
This Joint Meeting is the important basis of continued collaboration and partnership on basic and clinical pharmacology between Japan and China. This Joint Meeting is planned to provide excellent opportunities to discuss among the scientists for pharmacological research, and to foster active pharmacologists responsible for international collaboration in the future. This meeting is sponsored by several Japanese foundations. The organizing committee appreciates their great contributions for giving us this opportunity for organizing the wonderful lectures on basic and clinical pharmacology. It is worth noting that this will be the first Joint Meeting to be held online due to the epidemic of COVID-19 infections in the world.
Mitsuhiro Yoshioka, M.D., Ph.D
President, The 94th Annual Meeting of the Japanese Pharmacological Society
Dean, Faculty of Medicine, Hokkaido University
Professor, Department of Neuropharmacology, Faculty of Medicine, Hokkaido University
Kazuhiko Yanai, MD., Ph.D.
President, the Japanese Pharmacological Society
Professor, Department of Pharmacology, Tohoku University Graduate School of Medicine
As the 8th Japan-China Joint Meeting of Basic and Clinical Pharmacology is coming, on behalf of Chinese Pharmacological Society, I wish to extend our warm greetings and sincere invitations to all our colleagues on pharmacological research in both Japan and China.
With great endeavors and struggles, we bid farewell to the extraordinary 2020, and embraced the beautiful spring of 2021. Looking back at 2020, The sudden pandemic of COVID-19 hit the world with a great threat to the people’s life and health. People around the world went all out to fight the pandemic, and have achieved great progress. During this process, we deeply realized the important role of science and technology, and also the essential significance of innovation and rapid new drug R&D in prevention and control of the pandemic.
The Japan-China Joint Meeting of Basic and Clinical Pharmacology co-organized by the Chinese Pharmacological Society (CNPHARS), the Japanese Pharmacological Society (JPS) and the Japanese Society of Clinical Pharmacology and Therapeutics (JSCPT) has been successfully held for 7 times, playing an important role in promoting the academic exchanges and cooperation, improving the mutual understanding and friendship, and boosting the development of pharmacology in our two countries.
The topics of this joint meeting are Molecular Pharmacology Study and Early Clinical Trials related pharmacological research which are all the current hot research areas in basic pharmacology and clinical pharmacology. Due to COVID-19, this meeting will be a virtual one. JPS and JSCPT are making thoughtful and meticulous preparations for this event. We believe that the meeting will be a complete success as always.
Dear colleagues, welcome to attend this meeting, take part in the scientific communications, and make new contributions to the development of pharmacology.
The President of Chinese Pharmacological Society
Jianguo Chen (Tongji Med. Coll., Huazhong Univ. Sci. Technol.)
Yoshikatsu Kanai (Grad. Sch. Med., Osaka Univ.)
Wei Wei (Inst. Clin. Pharmacol., Anhui Med. Univ.)
Ichiro Ieiri (Grad. Sch. Pharmaceut. Sci. Kyushu Univ.)
|Networks of organelle function in cardiovascular diseases
Yong Zhang (Dept. Pharmacol., Coll. Pharm., Harbin Med. Univ.)
|Redox regulation of mitochondrial quality as a therapeutic target of cardiac senescence
Motohiro Nishida (Grad. Sch. Pharm. Sci., Kyushu Univ. / NIPS)
|Accelerating development of proton pump inhibitors: a mechanism-based PK/PD model to optimize dose design with ilaprazole as a case drug
Hongyun Wang (Clin. Pharm. Res. Cent., Peking Union Med. Coll. Hosp.)
|Development of endogenous biomarkers to assess drug-transporter-mediated drug-drug interactions in drug development
Hiroyuki Kusuhara (Grad. Sch. Pharm. Sci., Univ. Tokyo)
|The Japanese Pharmacological Society
* The presentation order will be changed as follows:
1. Hongyun Wang(3-S32-3)
2. Hiroyuki Kusuhara(3-S32-4)
3. Yong Zhang(3-S32-1)
4. Motohiro Nishida(3-S32-2)